A office building designed by Frank or. Jerry on the Novartis headquarters AG in Basel, Switzerland.
Bloomberg Gety pictures
Swiss pharmaceutical giant Novartis On Friday, I mentioned better sales than expected in the fourth quarter, but less than its instructions throughout the entire year.
The fourth quarter sales increased by 16 % on the basis of a fixed currency to $ 13.2 billion, compared to $ 12.795 billion, estimated by analysts in the LSEG survey.
The basic operating income, the semester, reached $ 4.86 billion, for $ 4.23 billion.
For 2024, net sales increased by 12 % on the basis of a fixed currency to 50.32 billion dollars, compared to $ 50.47 billion. The basic operating income for the entire year increased by 22 % to $ 19.5 billion, compared to $ 17.02 billion expected.
Novartis raised its profits for the year 2024 for the third quarter in a row in October, saying that it expects net sales throughout the whole year and entered the basic operation of both centenary “teenagers” versus “Mediterranean teenagers to the two”.
This is an urgent news story and will be updated soon.
